Relationships among diabetic retinopathy, antioxidants, and glycemic control

Optometry and Vision Science

Volumn 88, Issue 2, 2011, Pages 251-256

  Lam, Carly S Y ^a   Benzie, Iris F F ^a   Choi, Siu Wai ^a   Chan, Lily Y L ^a   Yeung, Vincent T F ^b   Woo, George C ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b Our Lady of Maryknoll Hospital Hong Kong   (Hong Kong)

Author keywords

antioxidants; oxidative stress; retinopathy; type 2 diabetes

Indexed keywords

ANTIOXIDANT STATUS; ANTIOXIDANTS; DEMOGRAPHIC DATA; DIABETIC RETINOPATHY; DNA DAMAGES; GLYCEMIC CONTROL; HONG-KONG; IDENTIFICATION OF INDIVIDUALS; PLASMA ASCORBIC ACID; PLASMA GLUCOSE; RETINOPATHY; RISK FACTORS; TYPE 2 DIABETES; TYPE 2 DIABETES MELLITUS; VISION LOSS;

BIOMARKERS; BLOOD; BLOOD PRESSURE; DNA; GLUCOSE; KETONES; NUCLEIC ACIDS; ORGANIC ACIDS; OXIDATIVE STRESS; POPULATION STATISTICS;

EYE PROTECTION;

ANTIOXIDANT; ASCORBIC ACID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DIABETIC RETINOPATHY; DIET RESTRICTION; DNA DAMAGE; GENETICS; GLUCOSE BLOOD LEVEL; HONG KONG; HUMAN; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREVALENCE; RISK FACTOR;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA DAMAGE; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HONG KONG; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; RISK FACTORS;

EID: 79551566313     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e318208494a     Document Type: Article

References (21)

1. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006;73:126-34.
2. World Health Organization. Programmes and Projects: Prevention of Blindness and Visual Impairment: Causes of Blindness and Visual Impairment: Diabetic Retinopathy. Available at: Http:// www.who.int/blindness/causes/ priority/en/index6.html. Accessed September 6, 2010.
3. Shogbon AO, Levy SB. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia. Am J Health Syst Pharm 2010;67:798-805.
4. Tam VH, Lam EP, Chu BC, Tse KK, Fung LM. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complications 2009;23:185-93.
5. Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233-44.
6. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM. Acute hyperglycemia and oxidative stress: Direct cause and effect? Free Radic Biol Med 2008;44:1217-31.
7. Will JC, Ford ES, Bowman BA. Serum vitamin C concentrations and diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 1999;70:49-52.
8. Han Y, BearseMAJr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci 2004;45:948-54.
9. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98:786-806.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
12. Rizvi AA. Type 2 diabetes: Epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach. South Med J 2004;97:1079-87.
13. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010;375: 481-9.
14. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
15. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
17. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: A systematic review. Eye (Lond) 2004;18:963-83.
18. Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J 2005;11:438-44.
19. Datiles MB III, Ansari RR, Suh KI, Vitale S, Reed GF, Zigler JS Jr, Ferris FL III. Clinical detection of precataractous lens protein changes using dynamic light scattering. Arch Ophthalmol 2008;126: 1687-93.
20. Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T, Akagi Y. Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Ophthalmol Vis Sci 2006;47: 2061-4.
21. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.